Two Doses of Polatuzumab Vedotin in Patients With Relapsed/Refractory Follicular Lymphoma
2:25
Two Doses of Polatuzumab Vedotin in Patients With Relapsed/Refract…
381 viewsJun 11, 2015
YouTubeTargeted Oncology
Polatuzumab vedotin combined with chemotherapy in untreated large B-cell lymphoma
1:15
Polatuzumab vedotin combined with chemotherapy in untreated large …
345 viewsFeb 13, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC
Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC
311 viewsJun 27, 2024
vumedi.com
Dr. Kahl Discusses Polatuzumab Vedotin in Lymphoma
2:19
Dr. Kahl Discusses Polatuzumab Vedotin in Lymphoma
454 viewsJul 19, 2018
YouTubeOncLive
Polatuzumab vedotin and CAR T-cell therapy for diffuse large B-cell lymphoma
2:00
Polatuzumab vedotin and CAR T-cell therapy for diffuse large B-cell lym…
704 viewsJul 12, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients With Relapsed/Refractory LBCL: Primary Analysis of a Phase Ib/II Study | OncLive
10:52
Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorabl…
Dec 22, 2023
onclive.com
Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial
Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial
368 viewsJun 26, 2024
vumedi.com
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent …
1 month ago
vumedi.com
Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial
243 viewsJul 8, 2024
vumedi.com
Dr. Perez Perez on Results From a Retrospective Study of Polatuzum…
Feb 10, 2023
onclive.com
POLIVY® (polatuzumab vedotin-piiq) Mechanism of Action
Aug 14, 2023
polivy-hcp.com
2:12
Up to 40% of patients receiving the standard R-CHOP regimen for diff…
5.6K viewsJan 27, 2022
FacebookThe New England Journal of Medicine
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfo…
198 viewsJun 6, 2024
vumedi.com
2:13
For patients with recurrent cervical cancer, limited treatment options …
969 viewsJul 9, 2024
FacebookThe New England Journal of Medicine
0:56
Promising Results for Bendamustine/Rituximab Plus Pol…
590 viewsSep 27, 2018
YouTubeTargeted Oncology
Disitamab Vedotin: Promising HER2-Targeted Therapy for Uroth…
Sep 15, 2024
urotoday.com
Erdafitinib versus enfortumab vedotin in previously treated uroth…
Apr 6, 2021
urologytimes.com
7:16
Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R …
177 viewsAug 5, 2021
YouTubeecancer
1:59
Polatuzumab vedotin combined with R-ICE as second-line therapy in R/…
231 viewsMay 17, 2023
YouTubeecancer
0:54
Polatuzumab Vedotin: A New Hope in Blood Cancer Treatment
261 views9 months ago
YouTubeDr. Rajib Bhattacharjee
4:36
Polatuzumab Vedotin: A New Hope in Blood Cancer Treatment
57 views9 months ago
YouTubeDr. Rajib Bhattacharjee
Dr Goldman on the Efficacy of Telisotuzumab Vedotin in Advanc…
11 months ago
onclive.com
2:30
Brentuximab vedotin for treating Hodgkin Lymphoma
1.2K viewsSep 28, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:59
Brentuximab vedotin with chemotherapy for advanced classi…
613 viewsAug 5, 2021
YouTubeecancer
4:13
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma
156 viewsJun 20, 2018
YouTubeecancer
2:36
The predictive value of cell-of-origin subtype in patients with DLBCL re…
217 viewsDec 18, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:39
Future Use of Novel Therapy in DLBCL
84 viewsNov 25, 2019
YouTubeTargeted Oncology
3:34
Evolving Role of Brentuximab Vedotin in Hodgkin Lymphoma
302 viewsApr 2, 2015
YouTubeOncLive
5:46
Glofitamab and polatuzumab vedotin in DLBCL
811 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:59
A breakthrough therapy: polatuzumab vedotin plus BR for …
2.5K viewsJun 16, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder